Loading...
•
Dec 31, 2020
Conmed Q4 2020 Earnings Report
Announced financial results for the fourth quarter ended December 31, 2020.
Key Takeaways
CONMED Corporation reported their Q4 2020 financial results, highlighting the resilience of their team in a challenging operating environment due to the ongoing impacts of COVID-19 on surgical procedure volumes.
CONMED faced challenges in Q4 2020 due to the impact of COVID-19 on surgical procedure volumes.
The company expects improvement in procedure volumes as vaccines become more readily available in 2021.
CONMED anticipates full-year 2021 revenue between $975 million and $1.02 billion.
The company forecasts full-year 2021 adjusted diluted net earnings per share in the range of $2.85 to $3.05.
Forward Guidance
The Company expects full-year 2021 revenue between $975 million and $1.02 billion and forecasts full-year 2021 adjusted diluted net earnings per share in the range of $2.85 to $3.05.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...